186 related articles for article (PubMed ID: 14507652)
21. Identification of altered MicroRNA expression patterns in synovial sarcoma.
Hisaoka M; Matsuyama A; Nagao Y; Luan L; Kuroda T; Akiyama H; Kondo S; Hashimoto H
Genes Chromosomes Cancer; 2011 Mar; 50(3):137-45. PubMed ID: 21213367
[TBL] [Abstract][Full Text] [Related]
22. Sox10 and S100 in the diagnosis of soft-tissue neoplasms.
Karamchandani JR; Nielsen TO; van de Rijn M; West RB
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):445-50. PubMed ID: 22495377
[TBL] [Abstract][Full Text] [Related]
23. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
[TBL] [Abstract][Full Text] [Related]
24. Synovial sarcoma: a new approach to the histological classification and a comparison with malignant mesothelioma. Immunohistochemical study with anti-mesothelial cell serum.
Ryś J; Donna A; Betta PG; Robutti F; Bellingeri D; Szklarski W; Gruchała A; Niezabitowski A
Patol Pol; 1992; 43(4):161-3. PubMed ID: 1283781
[TBL] [Abstract][Full Text] [Related]
25. Radiation-associated synovial sarcoma: clinicopathologic and molecular analysis of two cases.
Egger JF; Coindre JM; Benhattar J; Coucke P; Guillou L
Mod Pathol; 2002 Sep; 15(9):998-1004. PubMed ID: 12218218
[TBL] [Abstract][Full Text] [Related]
26. Monophasic, glandular, synovial sarcomas and carcinomas of the soft tissues.
Farris KB; Reed RJ
Arch Pathol Lab Med; 1982 Mar; 106(3):129-32. PubMed ID: 6277272
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution.
Hornick JL; Fletcher CD
Am J Clin Pathol; 2002 Feb; 117(2):188-93. PubMed ID: 11865845
[TBL] [Abstract][Full Text] [Related]
28. Tissue microarray based immunohistochemical study of TLE1 in synovial sarcoma and its histologic mimics.
Sivakoti S; Uppin SG; Uppin MS; Tara RP; Prayaga AK; Challa S
Indian J Pathol Microbiol; 2021; 64(2):310-315. PubMed ID: 33851625
[TBL] [Abstract][Full Text] [Related]
29. Cytologic features of synovial sarcoma with emphasis on the monophasic fibrous variant: a morphologic and immunocytochemical analysis of bcl-2 protein expression.
Viguer JM; Jiménez-Heffernan JA; Vicandi B; López-Ferrer P; Gamallo C
Cancer; 1998 Feb; 84(1):50-6. PubMed ID: 9500652
[TBL] [Abstract][Full Text] [Related]
30. Demonstration of myxoid change in fine-needle aspiration of synovial sarcoma: a case report.
Moffatt EJ; Liu K; Layfield LJ
Diagn Cytopathol; 1998 Mar; 18(3):188-91. PubMed ID: 9523136
[TBL] [Abstract][Full Text] [Related]
31. KIT activation in soft tissue sarcomas.
Tamborini E; Bonadiman L; Moiraghi L; Pilotti S; Pierotti MA
Am J Clin Pathol; 2002 Sep; 118(3):472-3; author reply 473. PubMed ID: 12219791
[No Abstract] [Full Text] [Related]
32. Diagnostic utility of dual-color break-apart chromogenic in situ hybridization for the detection of rearranged SS18 in formalin-fixed, paraffin-embedded synovial sarcoma.
Motoi T; Kumagai A; Tsuji K; Imamura T; Fukusato T
Hum Pathol; 2010 Oct; 41(10):1397-404. PubMed ID: 20594581
[TBL] [Abstract][Full Text] [Related]
33. Cyclooxygenase-2 expression is not associated with clinical outcome in synovial sarcoma.
Carmody Soni EE; Miller BJ; Scarborough MT; Reith J; Gibbs CP
Oncol Rep; 2011 Dec; 26(6):1513-7. PubMed ID: 21874258
[TBL] [Abstract][Full Text] [Related]
34. Transducer-like Enhancer of Split 1 as a Novel Immuno- histochemical Marker for Diagnosis of Synovial Sarcoma.
Atef A; Alrashidy M
Asian Pac J Cancer Prev; 2015; 16(15):6545-8. PubMed ID: 26434872
[TBL] [Abstract][Full Text] [Related]
35. Ossifying synovial sarcoma.
Hisaoka M; Matsuyama A; Shimajiri S; Akiba J; Kusano H; Hiraoka K; Shoda T; Hashimoto H
Pathol Res Pract; 2009; 205(3):195-8. PubMed ID: 19041192
[TBL] [Abstract][Full Text] [Related]
36. [Imprint cytological features of soft tissue sarcomas].
Sonobe H
Rinsho Byori; 1999 Jul; 47(7):614-21. PubMed ID: 10442039
[TBL] [Abstract][Full Text] [Related]
37. Synovial sarcoma: an immunohistochemical and ultrastructural study.
Ordóñez NG; Mahfouz SM; Mackay B
Hum Pathol; 1990 Jul; 21(7):733-49. PubMed ID: 2163364
[TBL] [Abstract][Full Text] [Related]
38. C-erb-B2 (HER2/neu) expression in synovial sarcoma of the head and neck.
Olsen RJ; Lydiatt WM; Koepsell SA; Lydiatt D; Johansson SL; Naumann S; Bridge JA; Neff JR; Hinrichs SH; Tarantolo SR
Head Neck; 2005 Oct; 27(10):883-92. PubMed ID: 16158422
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of apoptosis in synovial sarcoma: correlation with clinicopathologic parameters, cell proliferative activity, and expression of apoptosis-related proteins.
Kawauchi S; Fukuda T; Oda Y; Saito T; Oga A; Takeshita M; Yokoyama K; Chuman H; Iwamoto Y; Sasaki K; Tsuneyoshi M
Mod Pathol; 2000 Jul; 13(7):755-65. PubMed ID: 10912935
[TBL] [Abstract][Full Text] [Related]
40. [Expressions and significance of E-cadherin and beta-catenin in synovial sarcoma].
Sun BC; Sun Y; Zhao XL; Liu YX; Zhang SW; Liu YX
Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):727-30. PubMed ID: 16483482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
